Pharmacokinetics of Tolfenamic Acid Administered Orally and Intravenously at Different Doses in Pekin Ducks (Anas platyrhynchos domestica)
Animals · 08.08.2025 · 15 (16) · 2326
DOI: 10.3390/ani15162326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animals, online erschienen am 08.08.2025. Verfasst von Orhan Corum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay 31060, Türkiye. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Coordination of Scientific Research Projects, University of Selcuk, Türkiye, Coordination of Scientific Research Projects, University of Selcuk, Türkiye.
Abstract (Originalsprache)
This study aimed to examine the pharmacokinetic changes in tolfenamic acid administered intravenously and orally to ducks at different doses (2, 4, and 8 mg/kg). Furthermore, the binding ratio to plasma proteins was assessed utilizing the ultrafiltration method. Eighteen male Pekin ducks were randomly assigned to three dosage groups (2, 4, and 8 mg/kg), with each group undergoing a trial in two phases: intravenous (IV) and oral administration. The sample was analyzed using an approved HPLC-UV method. A non-compartmental analysis was utilized to evaluate the pharmacokinetic data. For 2 mg/kg IV injection, the area under the curve from zero to infinity (AUC0-∞), total clearance (ClT), volume of distribution at steady state (Vdss), and elimination half-life (t1/2ʎz) were 13.03 h*µg/mL, 0.15 L/h/kg, 0.30 L/kg, and 1.72 h, respectively. Following oral administration at a dose of 2 mg/kg, the AUC0-∞, peak plasma concentration (Cmax), and bioavailability were 6.32 h*µg/mL, 2.25 µg/mL, and 48.52%, respectively. The t1/2ʎz was extended, Cmax and AUC0-∞ elevated, Tmax shortened, and ClT decreased in a dose-dependent manner. No dose-related change was observed in Vdss and bioavailability. In ducks, tolfenamic acid’s plasma protein binding was 99.74%, unaffected by concentration. These results may contribute to the application of tolfenamic acid in ducks at different doses, but dose-related changes in therapeutic efficacy should also be demonstrated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay 31060, Türkiye.
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Selcuk, Konya 42031, Türkiye.
- Department of Pharmacology, Faculty of Veterinary Medicine, University of Murcia, 30100 Murcia, Spain.
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Siirt, Siirt 56100, Türkiye.
ORCID-Profile: Orhan Corum, Kamil Uney, Pedro Marin, Duygu Durna Corum, Elena Badillo, Muammer Elmas
Förderung
- The Coordination of Scientific Research Projects, University of Selcuk, Türkiye
- Coordination of Scientific Research Projects, University of Selcuk, Türkiye
Zitieren
APA
Corum, O., Uney, K., Marin, P., Corum, D. D., Coskun, D., Badillo, E., & Elmas, M. (2025). Pharmacokinetics of Tolfenamic Acid Administered Orally and Intravenously at Different Doses in Pekin Ducks (Anas platyrhynchos domestica). Animals, 15(16), 2326. https://doi.org/10.3390/ani15162326
Vancouver
Corum O, Uney K, Marin P, Corum DD, Coskun D, Badillo E, et al. Pharmacokinetics of Tolfenamic Acid Administered Orally and Intravenously at Different Doses in Pekin Ducks (Anas platyrhynchos domestica). Animals. 2025;15(16):2326. doi:10.3390/ani15162326
BibTeX
@article{Corum2025,
author = {Corum, Orhan and Uney, Kamil and Marin, Pedro and Corum, Duygu Durna and Coskun, Devran and Badillo, Elena and Elmas, Muammer},
title = {Pharmacokinetics of Tolfenamic Acid Administered Orally and Intravenously at Different Doses in Pekin Ducks (Anas platyrhynchos domestica)},
journal = {Animals},
year = {2025},
volume = {15},
number = {16},
pages = {2326},
doi = {10.3390/ani15162326}
}
EUVIMED